A detailed history of Swiss National Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Swiss National Bank holds 1,788,600 shares of EW stock, worth $134 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,788,600
Previous 1,780,300 0.47%
Holding current value
$134 Million
Previous $164 Million 28.23%
% of portfolio
0.08%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$59.7 - $93.78 $495,510 - $778,374
8,300 Added 0.47%
1,788,600 $118 Million
Q2 2024

Aug 08, 2024

SELL
$84.3 - $94.31 $3.03 Million - $3.4 Million
-36,000 Reduced 1.98%
1,780,300 $164 Million
Q1 2024

May 07, 2024

SELL
$72.54 - $95.56 $6.14 Million - $8.09 Million
-84,700 Reduced 4.46%
1,816,300 $174 Million
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $3.02 Million - $3.8 Million
-48,900 Reduced 2.51%
1,901,000 $145 Million
Q3 2023

Nov 08, 2023

SELL
$69.28 - $93.38 $16.6 Million - $22.3 Million
-239,100 Reduced 10.92%
1,949,900 $135 Million
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $21.5 Million - $25 Million
-264,600 Reduced 10.78%
2,189,000 $206 Million
Q1 2023

May 10, 2023

SELL
$74.26 - $84.51 $4.9 Million - $5.58 Million
-66,000 Reduced 2.62%
2,453,600 $203 Million
Q4 2022

Feb 08, 2023

SELL
$68.3 - $87.44 $11.9 Million - $15.3 Million
-174,825 Reduced 6.49%
2,519,600 $188 Million
Q3 2022

Nov 09, 2022

SELL
$82.37 - $107.29 $807,226 - $1.05 Million
-9,800 Reduced 0.36%
2,694,425 $223 Million
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $8,650 - $12,827
100 Added 0.0%
2,704,225 $257 Million
Q1 2022

May 09, 2022

BUY
$101.96 - $128.34 $34.1 Million - $43 Million
334,900 Added 14.14%
2,704,125 $318 Million
Q4 2021

Feb 08, 2022

SELL
$106.37 - $130.68 $9.45 Million - $11.6 Million
-88,800 Reduced 3.61%
2,369,225 $307 Million
Q3 2021

Nov 08, 2021

SELL
$102.91 - $122.75 $9.11 Million - $10.9 Million
-88,500 Reduced 3.48%
2,458,025 $278 Million
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $12.6 Million - $15.7 Million
149,716 Added 6.25%
2,546,525 $264 Million
Q1 2021

May 07, 2021

BUY
$78.68 - $90.67 $3.82 Million - $4.41 Million
48,600 Added 2.07%
2,396,809 $200 Million
Q4 2020

Feb 05, 2021

SELL
$71.69 - $91.23 $4.57 Million - $5.82 Million
-63,800 Reduced 2.65%
2,348,209 $214 Million
Q3 2020

Nov 09, 2020

SELL
$67.19 - $87.44 $4.36 Million - $5.67 Million
-64,900 Reduced 2.62%
2,412,009 $193 Million
Q2 2020

Aug 05, 2020

BUY
$57.54 - $76.95 $95.9 Million - $128 Million
1,667,406 Added 205.98%
2,476,909 $171 Million
Q1 2020

May 08, 2020

BUY
$52.41 - $81.0 $8.06 Million - $12.5 Million
153,800 Added 23.46%
809,503 $153 Million
Q4 2019

Feb 06, 2020

SELL
$71.7 - $82.09 $2.35 Million - $2.69 Million
-32,800 Reduced 4.76%
655,703 $153 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $646,582 - $792,392
10,505 Added 1.55%
688,503 $151 Million
Q2 2019

Aug 02, 2019

SELL
$55.74 - $64.41 $1.1 Million - $1.27 Million
-19,700 Reduced 2.82%
677,998 $125 Million
Q1 2019

May 10, 2019

BUY
$47.89 - $64.05 $814,130 - $1.09 Million
17,000 Added 2.5%
697,698 $133 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $357,357 - $438,438
7,700 Added 1.14%
680,698 $104 Million
Q3 2018

Nov 08, 2018

SELL
$45.7 - $58.03 $987,120 - $1.25 Million
-21,600 Reduced 3.11%
672,998 $117 Million
Q2 2018

Aug 09, 2018

BUY
$42.45 - $51.3 $666,465 - $805,410
15,700 Added 2.31%
694,598 $101 Million
Q1 2018

May 04, 2018

SELL
$37.19 - $47.45 $3.71 Million - $4.74 Million
-99,800 Reduced 12.82%
678,898 $94.7 Million
Q4 2017

Feb 07, 2018

BUY
$33.79 - $39.39 $118,265 - $137,865
3,500 Added 0.45%
778,698 $87.8 Million
Q3 2017

Nov 03, 2017

BUY
$36.29 - $38.83 $28.1 Million - $30.1 Million
775,198
775,198 $84.7 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.